Tri Locum Partners LP Q1 2025 Filing
Filed May 14, 2025
Portfolio Value
$194.9B
Holdings
22
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CITHE CIGNA GROUP | 73,905 | $24.3B | 12.48% | |
| 2 | MCKMCKESSON CORP | 26,944 | $18.1B | 9.30% | |
| 3 | SLNOSOLENO THERAPEUTICS INC | 234,920 | $16.8B | 8.61% | |
| 4 | TEVATEVA PHARMACEUTICAL INDS LTD | 1,061,008 | $16.3B | 8.37% | |
| 5 | INSPINSPIRE MED SYS INC | 78,812 | $12.6B | 6.44% | |
| 6 | MDGLMADRIGAL PHARMACEUTICALS INC | 37,869 | $12.5B | 6.44% | |
| 7 | AXSMAXSOME THERAPEUTICS INC | 101,240 | $11.8B | 6.06% | |
| 8 | ARGXARGENX SE | 17,844 | $10.6B | 5.42% | |
| 9 | GILDGILEAD SCIENCES INC | 89,453 | $10.0B | 5.14% | |
| 10 | ILMNILLUMINA INC | 120,729 | $9.6B | 4.91% | |
| 11 | IM8NINSMED INC | 101,859 | $7.8B | 3.99% | |
| 12 | NUVLNUVALENT INC | 95,825 | $6.8B | 3.49% | |
| 13 | MRUSMERUS N V | 156,915 | $6.6B | 3.39% | |
| 14 | WGSGENEDX HOLDINGS CORP | 58,145 | $5.1B | 2.64% | |
| 15 | ASNDASCENDIS PHARMA A/S | 32,325 | $5.0B | 2.58% | |
| 16 | 2L9BLUEPRINT MEDICINES CORP | 50,000 | $4.4B | 2.27% | |
| 17 | EOLSEVOLUS INC | 321,802 | $3.9B | 1.99% | |
| 18 | VERAVERA THERAPEUTICS INC | 150,207 | $3.6B | 1.85% | |
| 19 | STVNSTEVANATO GROUP S P A | 175,681 | $3.6B | 1.84% | |
| 20 | PRAXPRAXIS PRECISION MEDICINES I | 83,659 | $3.2B | 1.63% | |
| 21 | KRROKORRO BIO INC | 128,381 | $2.2B | 1.15% | |
| 22 | FEMYFEMASYS INC | 30,606 | $38.3M | 0.02% |